ArticleHaematologica2026

CD20 re-emergence in a patient with diffuse large B-cell lymphoma who experienced a CD20-negative relapse after glofitamab treatment.

Pranya Gaddipati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.